Current cover

Recent in Regulatory (page 2 of 38)

FDA Warns CBD Company Making Unsubstantiated Marketing Claims

The agency has issued a warning letter to Curaleaf Inc., for illegally selling unapproved products containing cannabidiol (CBD) online. The company is accused of making unsubstantiated claims that the products treat cancer, Alzheimer’s disease and opioid withdrawal, among other conditions or diseases.

Phthalates Flagged for Endocrine Disruption

Having already made the REACh list of chemicals requiring authorization, four phthalates are now recommended by European legislators to be flagged as endocrine disruptors.

The INCI Name Game: A Commentary

When misinformed groups play in a technical space, nontechnically trained regulators make irrelevant rules, and INCI names are generalized and misused, you have the perfect storm for consumer confusion.

Imported Cosmetic Inspections Questioned by U.S. Congressman

A U.S. Congressman has requested data from the U.S. Food and Drug Administration on its policies on cosmetic imports.

EU, Mercosur Strike Trade Deal More Than 20 Years in the Making

Per an EU statement the deal will remove the majority of tariffs on EU exports to Mercosur, which is comprised of Argentina, Brazil, Paraguay and Uruguay, as well as several associate members.

Diatomaceous Earth and Comfrey Root Catch the FDA's Eye

This is a good reminder for cosmetic manufacturers to be careful when straddling the line between a cosmetic and drug. It's all in the claims.

Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics

There is no outright prohibition against CBD-containing cosmetics, but this does not mean hemp products will no longer be regulated. This article reviews the ins and outs of CBD cosmetic compliance as the current U.S. legislation stands.

Article sponsored by Ashland

Claire's, Beauty Plus Global Recall Certain Cosmetics After Asbestos Testing

The voluntary recalls are a result of the U.S. Food and Drug Administration's ongoing testing for asbestos in cosmetics.

When it Comes to CBD, the FDA Wants to See the Receipts

The agency held its first hearing on cannabidiol (CBD) in Silver Spring, Maryland, on Friday, May 31, 2019.

Minnesota Joins States Lifting School Sunscreen Bans

Students may now use sunscreen during the school day on school property or at school-sponsored events. The language was added to an education finance budget bill signed by Gov. Tim Walz.

Cruelty-Free Cosmetics Act Advances in Canadian House of Commons

The bill aims to prohibit any and all animal testing for cosmetic purposes in the country. It would also ban the sale of cosmetic products or ingredients that rely on the results of new animal-testing performed anywhere else in the world.

EU Regulatory Update on the Future of Hair Color Warnings, Plus Brexit and Cannabis

Hair dyes are covered by strict legislative frameworks around the world to avoid adverse reactions; this column covers new research that may add heft to their warning labels. Updates to ongoing regulatory considerations for Brexit and cannabis use also are discussed.

Can't find what you're looking for? Try searching, or looking through past issues.